Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Andrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, Vito Amoroso & Alfredo Berruti. (2014) Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. Expert Opinion on Investigational Drugs 23:12, pages 1619-1635.
Read now
Read now
C Jonas, Ph Eucher, Th Gustin & JE Donckier. (2013) CHRONIC NECROTISING ASPERGILLOSIS MIMICKING ACTH-SECRETING TUMOUR IN A CASE OF CUSHING’S DISEASE. Acta Clinica Belgica 68:2, pages 143-146.
Read now
Read now
Farah H Morgan & Marc Laufgraben. (2013) Medical management of Cushing’s syndrome. Expert Review of Endocrinology & Metabolism 8:2, pages 183-193.
Read now
Read now
Articles from other publishers (42)
R. Pivonello, C. Scaroni, B. Polistena, A. Migliore & A. Giustina. (2023) Unmet needs on the current medical management of Cushing’s syndrome: results from a Delphi panel of Italian endocrinologists. Journal of Endocrinological Investigation.
Crossref
Crossref
Robert van Wilpe, Abraham H. Hulst, Sarah.E. Siegelaar, J. Hans DeVries, Benedikt Preckel & Jeroen Hermanides. (2023) Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know. Journal of Clinical Anesthesia 84, pages 111012.
Crossref
Crossref
Shlomo Melmed, Ursula B Kaiser, M Beatriz Lopes, Jerome Bertherat, Luis V Syro, Gerald Raverot, Martin Reincke, Gudmundur Johannsson, Albert Beckers, Maria Fleseriu, Andrea Giustina, John A H Wass & Ken K Y Ho. (2022) Clinical Biology of the Pituitary Adenoma. Endocrine Reviews 43:6, pages 1003-1037.
Crossref
Crossref
Stefano Frara, Luigi di Filippo, Mauro Doga, Paola Loli, Felipe F. Casanueva & Andrea Giustina. (2022) Novel approaches to bone comorbidity in Cushing’s disease: an update. Pituitary 25:5, pages 754-759.
Crossref
Crossref
Andrea Pence, Megan McGrath, Stephanie L. Lee & Douglas E. Raines. (2022) Pharmacological management of severe Cushing’s syndrome: the role of etomidate. Therapeutic Advances in Endocrinology and Metabolism 13, pages 204201882110585.
Crossref
Crossref
Salem A. Beshyah, Mussa H. Almalki, Said Azzoug, Maya Barake, Khaled M. A. Al Dahmani & Melika Chihaoui. (2022) Diagnosis and Management of Cushing's Disease: A Survey of Endocrinologists from the Middle East and North Africa. Journal of Diabetes and Endocrine Practice 05:01, pages 021-028.
Crossref
Crossref
Baomin Wang, Yumei Yang, Haoyue Yuan & Xiaomu Li. (2021) Association between Neutrophilic Granulocyte Percentage and Diabetes Mellitus in Cushing’s Syndrome Patients: A Cross-Sectional Study. International Journal of Endocrinology 2021, pages 1-9.
Crossref
Crossref
Elena Heger, German Rubinstein, Leah T. Braun, Stephanie Zopp, Jürgen Honegger, Max Seidensticker, Martin Reincke & Andrea Oßwald. (2021) Chemosensory dysfunction in Cushing’s syndrome. Endocrine 73:3, pages 674-681.
Crossref
Crossref
Stefano Frara, Agnese Allora, Laura Castellino, Luigi di Filippo, Paola Loli & Andrea Giustina. (2021) COVID-19 and the pituitary. Pituitary 24:3, pages 465-481.
Crossref
Crossref
Stefano Frara, Agnese Allora, Luigi di Filippo, Anna Maria Formenti, Paola Loli, Elisabetta Polizzi, Daniele Tradati, Fabio Massimo Ulivieri & Andrea Giustina. (2021) Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease. Best Practice & Research Clinical Endocrinology & Metabolism 35:2, pages 101515.
Crossref
Crossref
Kim M.J.A. Claessen, Natasha M. Appelman-Dijkstra & Nienke R. Biermasz. 2021. Pituitary Tumors. Pituitary Tumors
617
637
.
Pietro Mortini, Gianluca Nocera, Francesca Roncelli, Marco Losa, Anna Maria Formenti & Andrea Giustina. (2020) The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective. Reviews in Endocrine and Metabolic Disorders 21:4, pages 527-536.
Crossref
Crossref
Zhuang Chen, Guoliang Wang & Che Jiang. (2019) Posttraumatic stress symptoms (PTSS) in patients with Cushing’s disease before and after surgery: A prospective study. Journal of Clinical Neuroscience 66, pages 1-6.
Crossref
Crossref
Gabriel J. Seifert, Gunnar Leithold, Birte Kulemann, Philipp A. Holzner, Torben Glatz, Jens Hoeppner, Simon Kirste, Goran Marjanovic & Claudia Laessle. (2018) The effect of pasireotide on intestinal anastomotic healing with and without whole-body irradiation in a rat model. International Journal of Colorectal Disease 34:2, pages 337-345.
Crossref
Crossref
Yuya Tsurutani, Kengo Miyoshi, Kosuke Inoue, Tomoko Takiguchi, Jun Saito, Masao Omura & Tetsuo Nishikawa. (2019) Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing’s syndrome. Endocrine Journal 66:3, pages 207-214.
Crossref
Crossref
Raven McGlotten, Daphne T. Adelman & Margaret F. Keil. 2019. Advanced Practice in Endocrinology Nursing. Advanced Practice in Endocrinology Nursing
395
414
.
Gherardo Mazziotti, Stefano Frara & Andrea Giustina. (2018) Pituitary Diseases and Bone. Endocrine Reviews 39:4, pages 440-488.
Crossref
Crossref
Asaka Sato & Yasushi Hara. (2018) Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs. Research in Veterinary Science 119, pages 61-66.
Crossref
Crossref
B. S. Yurekli, B. Karaca, A. Kisim, E. Bozkurt, H. Atmaca, S. Cetinkalp, G. Ozgen, C. Yilmaz, S. Uzunoglu, R. Uslu & F. Saygili. (2017) AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells. Journal of Endocrinological Investigation 41:2, pages 233-240.
Crossref
Crossref
Gherardo Mazziotti, Mauro Doga, Annamaria Formenti, Stefano Frara, Filippo Maffezzoni & Andrea Giustina. 2018. Hypothalamic-Pituitary Diseases. Hypothalamic-Pituitary Diseases
513
526
.
G. Mazziotti, M. Doga, A. M. Formenti, S. Frara, F. Maffezzoni & A. Giustina. 2017. Thyroid Diseases. Thyroid Diseases
1
15
.
Carla Scaroni, Marialuisa Zilio, Michelangelo Foti & Marco Boscaro. (2017) Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management. Endocrine Reviews 38:3, pages 189-219.
Crossref
Crossref
G. Mazziotti, A. M. Formenti, S. Frara, F. Maffezzoni, M. Doga & A. Giustina. (2017) Diabetes in Cushing Disease. Current Diabetes Reports 17:5.
Crossref
Crossref
Vladimir Neychev. 2017. Management of Adrenal Masses in Children and Adults. Management of Adrenal Masses in Children and Adults
159
178
.
Vladimir Neychev, Seth M. Steinberg, Lily Yang, Amit Mehta, Naris Nilubol, Margaret F. Keil, Lynnette Nieman, Constantine A. Stratakis & Electron Kebebew. (2015) Long-Term Outcome of Bilateral Laparoscopic Adrenalectomy Measured by Disease-Specific Questionnaire in a Unique Group of Patients with Cushing’s Syndrome. Annals of Surgical Oncology 22:S3, pages 699-706.
Crossref
Crossref
Gherardo Mazziotti, Silvia Chiavistelli & Andrea Giustina. (2015) Pituitary Diseases and Bone. Endocrinology and Metabolism Clinics of North America 44:1, pages 171-180.
Crossref
Crossref
Elise Bouw, Martin Huisman, Sebastian J.C.M.M. Neggers, Axel P.N. Themmen, A.J. van der Lely & Patric J.D. Delhanty. (2014) Development of potent selective competitive-antagonists of the melanocortin type 2 receptor. Molecular and Cellular Endocrinology 394:1-2, pages 99-104.
Crossref
Crossref
Diego Ferone, Claudia Pivonello, Giovanni Vitale, Maria Chiara Zatelli, Annamaria Colao & Rosario Pivonello. (2013) Molecular basis of pharmacological therapy in Cushing’s disease. Endocrine 46:2, pages 181-198.
Crossref
Crossref
A. Scillitani, G. Mazziotti, C. Di Somma, S. Moretti, A. Stigliano, R. Pivonello, A. Giustina & A. Colao. (2013) Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?. Osteoporosis International 25:2, pages 441-446.
Crossref
Crossref
Pablo Abellán Galiana, Carmen Fajardo Montañana, Pedro Antonio Riesgo Suárez, José Gómez Vela, Carlos Meseguer Escrivá & Vicente Rovira Lillo. (2013) Factores pronósticos de remisión a largo plazo tras cirugía transesfenoidal en la enfermedad de Cushing. Endocrinología y Nutrición 60:8, pages 475-482.
Crossref
Crossref
Pablo Abellán Galiana, Carmen Fajardo Montañana, Pedro Antonio Riesgo Suárez, José Gómez Vela, Carlos Meseguer Escrivá & Vicente Rovira Lillo. (2013) Predictors of long-term remission after transsphenoidal surgery in Cushing's disease. Endocrinología y Nutrición (English Edition) 60:8, pages 475-482.
Crossref
Crossref
Valeria Alcantara, Eulalia Urgell, J. Francesc Sancho & Ana Chico. (2013) Severe Ectopic Cushing Syndrome Caused by Adenoid Cystic Carcinoma of a Salivary Gland. Endocrine Practice 19:5, pages e118-e121.
Crossref
Crossref
Nilufer Alcalar, Sedat Ozkan, Pinar Kadioglu, Ozlem Celik, Penbe Cagatay, Baris Kucukyuruk & Nurperi Gazioglu. (2012) Evaluation of depression, quality of life and body image in patients with Cushing’s disease. Pituitary 16:3, pages 333-340.
Crossref
Crossref
John D. Carmichael & Maria Fleseriu. (2012) Mifepristone: is there a place in the treatment of Cushing’s disease?. Endocrine 44:1, pages 20-32.
Crossref
Crossref
Gherardo Mazziotti & Andrea Giustina. (2013) Glucocorticoids and the regulation of growth hormone secretion. Nature Reviews Endocrinology 9:5, pages 265-276.
Crossref
Crossref
G. S. Kolesnikova, A. M. Lapshina, I. A. Voronkova, E. I. Marova, S. D. Arapova, N. P. Goncharov & I. I. Dedov. (2013) Comparative Analysis of Clinical, Hormonal and Morphological Studies in Patients with Neuroendocrine ACTH-Producing Tumours. International Journal of Endocrinology 2013, pages 1-10.
Crossref
Crossref
María-José Barahona Constanzo & Carlos del Pozo Picó. (2012) Nuevas perspectivas en el tratamiento farmacológico de la enfermedad de Cushing. Endocrinología y Nutrición 59:10, pages 599-605.
Crossref
Crossref
María-José Barahona Constanzo & Carlos del Pozo Picó. (2012) New prospects for drug treatment in Cushing disease. Endocrinología y Nutrición (English Edition) 59:10, pages 599-605.
Crossref
Crossref
Jennifer Y. Han, Leili Mirsadraei, Michael W. Yeh, Jeffrey D. Suh, William H. Yong, Marvin Bergsneider & Anthony P. Heaney. (2012) Bilateral Adrenalectomy: Lifesaving Procedure in Severe Cushing Syndrome. Endocrine Practice 18:4, pages e85-e90.
Crossref
Crossref
L K Dzeranova, Yu V Pankratova, Z E Belaya, E A Pigarova, O V Manchenko, L Ya Rozhinskaya, A Yu Grigor'ev & G S Kolesnikova. (2012) Giperkortitsizm i metabolicheskiy sindrom: slozhnosti differentsial'noy diagnostiki i lecheniya. Obesity and metabolism 9:2, pages 57-61.
Crossref
Crossref
Ahmed RizkJuergen HoneggerMonika MilianTsambika Psaras. (2012) Treatment Options in Cushing's Disease. Clinical Medicine Insights: Oncology 6, pages CMO.S6198.
Crossref
Crossref
Constanza M López-Fontana, María E Maselli, Florencia E G de Di Nasso, Carlos M Telleria & Rubén W Carón. (2011) Regulation of prolactin secretion during the estrus in rats: possible role of glucocorticoids. REPRODUCTION 142:3, pages 477-485.
Crossref
Crossref